These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 4394707)
21. [Effect of 2 beta-blockers on arterial hypertension during pregnancy. Results of a prospective study on 56 pregnant hypertensive women treated with atenolol and labetalol]. Gérard J; Blazquez G; Lardoux H; Beauséjour B; Faurie C; Rousset D; Flouvat B J Gynecol Obstet Biol Reprod (Paris); 1983; 12(8):891-900. PubMed ID: 6672083 [TBL] [Abstract][Full Text] [Related]
23. [Effect on the cardiovascular system of a 3.5% gelatin infusion solution Gelafusal in hypertensive women in late pregnancy]. Retzke U; Schwarz R; Lauckner W; Daugott E Zentralbl Gynakol; 1978; 100(11):706-9. PubMed ID: 685555 [TBL] [Abstract][Full Text] [Related]
25. [Anti-hypertensive therapy in pregnancy-induced hypertension with urapidil]. Wacker J; Müller J; Grischke EM; Unkels R; Bastert G Zentralbl Gynakol; 1994; 116(5):271-3. PubMed ID: 8023622 [TBL] [Abstract][Full Text] [Related]
26. Adrenergic beta-receptor blockers in hypertension of pregnancy. Sandström B Clin Exp Hypertens B; 1982; 1(1):127-41. PubMed ID: 6135521 [TBL] [Abstract][Full Text] [Related]
27. In the dose range of 0.5-2.0 mg/kg, acetylsalicylic acid does not affect prostacyclin production in hypertensive pregnancies. Vainio M; Mäenpää J; Riutta A; Ylitalo P; Ala-Fossi SL; Tuimala R Acta Obstet Gynecol Scand; 1999 Feb; 78(2):82-8. PubMed ID: 10023867 [TBL] [Abstract][Full Text] [Related]
28. [Therapeutic problems of hypertension in pregnancy]. Pasetto N Clin Ter; 1984 Mar; 108(6):543-9. PubMed ID: 6233073 [No Abstract] [Full Text] [Related]
30. Report of the Canadian Hypertension Society Consensus Conference: 3. Pharmacologic treatment of hypertensive disorders in pregnancy. Rey E; LeLorier J; Burgess E; Lange IR; Leduc L CMAJ; 1997 Nov; 157(9):1245-54. PubMed ID: 9361646 [TBL] [Abstract][Full Text] [Related]
34. [Management of a severe hypertensive syndrome of pregnancy, in a base hospital]. Oyarzún Ebensperger E; Brañes Barrera J; Mesa Latorre T; Contreras C Rev Chil Obstet Ginecol; 1985; 50(3):212-24. PubMed ID: 3843273 [No Abstract] [Full Text] [Related]
35. [Cardiovascular effect of low-molecular dextran in advanced hypertensive pregnancies]. Schwarz R; Retzke U Zentralbl Gynakol; 1970 Mar; 92(11):328-32. PubMed ID: 5515930 [No Abstract] [Full Text] [Related]
36. [Evaluation of blood volume in normal pregnant patients and in hypertensive pregnant women treated with alpha-methyl-dopa]. Ferrazzani S; Bondoli A; Lombardo F; Rastelli D; Piccaro M; Meduri F; Magnotti DL; Moneta E Minerva Ginecol; 1982 Sep; 34(9):643-52. PubMed ID: 7145201 [No Abstract] [Full Text] [Related]
37. Antihypertensive effect of labetalol, a new alpha- and beta-adrenergic blocking agent. Hansson L; Hänel B Int J Clin Pharmacol Biopharm; 1976 Oct; 14(3):195-8. PubMed ID: 12115 [TBL] [Abstract][Full Text] [Related]
38. Hemodynamic effects of intravenous hydralazine in pregnant women with severe hypertension. Kuzniar J; Skret A; Piela A; Szmigiel Z; Zaczek T Obstet Gynecol; 1985 Oct; 66(4):453-8. PubMed ID: 4047535 [TBL] [Abstract][Full Text] [Related]
39. [The cardiovascular effect of regitine in pathological pregnancy]. Retzke U; Schwarz R Arch Gynakol; 1968; 205(3):287-94. PubMed ID: 5695183 [No Abstract] [Full Text] [Related]
40. [Treatment of the hypertensive syndrome with hemiton and isobarin in certain diseases of pregnant women]. Shekhtman MM; Volpin EA; Turenko AI; Zamanskaia EM Akush Ginekol (Mosk); 1977 Mar; (3):50-3. PubMed ID: 331984 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]